111 (YI) Net Cash Flow Growth (3y) (2020 - 2025)
111 (YI) Net Cash Flow Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 37.26% |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 83.11% |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 141.98% |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | -6.47% |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 47.18% |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | -51.20% |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -23.79% |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 26.38% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 474.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 44.39% |
| Sep 30, 2025 | -41.05% |
| Jun 30, 2025 | 19.35% |
| Mar 31, 2025 | 74.63% |
| Dec 31, 2024 | -38.20% |
| Sep 30, 2024 | 28.60% |
| Jun 30, 2024 | -41.75% |
| Mar 31, 2024 | 64.71% |
| Dec 31, 2023 | -37.83% |
| Sep 30, 2023 | -28.87% |
| Jun 30, 2023 | -26.82% |
| Mar 31, 2023 | 18.15% |
| Dec 31, 2022 | -29.66% |
| Sep 30, 2022 | -48.71% |
| Jun 30, 2022 | -35.06% |
| Mar 31, 2022 | 37.90% |
| Dec 31, 2021 | -33.52% |
| Sep 30, 2021 | -33.43% |
| Jun 30, 2021 | -37.57% |
| Mar 31, 2021 | -72.62% |